Patents Assigned to Arisaph Pharmaceuticals
  • Publication number: 20140018359
    Abstract: Disclosed are 6-(morpholinoalkyl)-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Application
    Filed: May 1, 2013
    Publication date: January 16, 2014
    Applicants: Arisaph Pharmaceuticals
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel Philip O'Connell, Wengen Wu, Christopher P. Kiritsy